Fresenius Kabi Pharma Portugal, L secures contract for Acquisition Of Tocilizumab 162 Mg/09 Ml (Biosimilar Fresenius) Sol Inj Pen, Seinga 09 Ml Sc

Portugal, Sept. 15 -- Portugal based Fresenius Kabi Pharma Portugal, L has secured contract from Unidade Local De Saude De Sao Jose, E. P. E. for Acquisition Of Tocilizumab 162 Mg/09 Ml (Biosimilar Fresenius) Sol Inj Pen, Seinga 09 Ml Sc. The value of the contract is worth 11423025 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....